Arapenta Injection
Purified Diphtheria Toxoid, Purified Tetanus Toxoid, Inactivated B. Pertussis, Hib oligosacharide (conjugated to CRM197 protein), Recombinant HBsAg
"NLT 30 IU, NLT 4 IU, NLT 60 IU, 10mcg, 10mcg/Dose"
ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO)
| Pack size | 0.5ml (1 Dose) Vial |
|---|---|
| Dispensing mode | POM |
| Source | SAUDI ARABIA |
| Agent | ALPHAMED DRUG STORE |
| Retail Price | 89.00 AED |
Indications
Arapenta Injection is used for:
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Purified Diphtheria Toxoid, Purified Tetanus Toxoid, Inactivated B. Pertussis, Hib oligosacharide (conjugated to CRM197 protein), Recombinant HBsAg :
Mechanism of Action
The DTaP vaccine consists of diphtheria and tetanus toxoids (inactivated toxins) and acellular pertussis antigens. The tetanus component of the vaccine is about 5 to 10 levels of flocculation (Lf) units of manufactured tetanus toxoid. The diphtheria component is a manufactured diphtheria toxoid of about 15 to 25 Lf units. The acellular pertussis component of a DTaP vaccine consists of manufactured pertussis antigens called pertussis toxin, filamentous haemagglutinin, pertactin, and fimbriae type 2 and 3.
Note
Arapenta "NLT 30 IU, NLT 4 IU, NLT 60 IU, 10mcg, 10mcg/Dose" Injection manufactured by ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO). Its generic name is Purified Diphtheria Toxoid, Purified Tetanus Toxoid, Inactivated B. Pertussis, Hib oligosacharide (conjugated to CRM197 protein), Recombinant HBsAg. Arapenta is availble in United Arab Emirates.
Farmaco UAE drug index information on Arapenta Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.